Cargando…
Clopidogrel Therapy Discontinuation Following Drug Eluting Stent Implantation in Real World Practice in Israel
BACKGROUND: Incidence and predictors of clopidogrel discontinuation after drug eluting stent (DES) implantation, in real world practice, are poorly known. METHODS: Prospective study included all patients who underwent implantation of at least one DES between February 2006 and January 2007. Predictor...
Autores principales: | Blich, Miry, Shwiri, Tawfiq Zeidan, Petcherski, Sirouch, Osherov, Azriel B, Hammerman, Haim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358143/ https://www.ncbi.nlm.nih.gov/pubmed/28348674 http://dx.doi.org/10.4021/cr146w |
Ejemplares similares
-
Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study
por: Thim, Troels, et al.
Publicado: (2014) -
Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers
por: Decker, Carole, et al.
Publicado: (2008) -
Acute Q Fever with Atrioventricular Block, Israel
por: Badarni, Karawan, et al.
Publicado: (2022) -
A Comparison of Two Brands of Clopidogrel in Patients With Drug-Eluting Stent Implantation
por: Park, Yae Min, et al.
Publicado: (2012) -
Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label study
por: Wykrzykowska, Joanna J., et al.
Publicado: (2009)